Prevalence of Type III Secretion Protein Exoenzymes and Antimicrobial Susceptibility Patterns from Bloodstream Isolates of Patients with Pseudomonas aeruginosa Bacteremia

References

• Jarvis WR, Martone WJ. Predominant pathogens in hos-pital infections. J Antimicrob Chemother 1992; 29 Suppl A:19-24.
   Google Scholar
• Bisbe J, Gatell JM, Puig J, et al. Pseudomonas aeruginosa bacteremia: univariate and multivariate analyses of factors influ-encing the prognosis in 133 episodes. Rev Infect Dis 1988; 10 (3): 629–35.
   PubMedGoogle Scholar
• Hilf M, Yu VL, Sharp J, Zuravleff JJ, Korvick JA, Muder RR. Antibiotic therapy for Pseudomonas aeruginosa bac-teremia: outcome correlations in a prospective study of 200 pa-tients. Am J Med 1989; 87 (5): 540–6.
   PubMed Web of Science ®Google Scholar
• Gallagher PG, Watanakunakorn C. Pseudomonas bac-teremia in a community teaching hospital, 1980-1984. Rev In-fect Dis 1989; 11 (6): 846–52.
   PubMedGoogle Scholar
• Mallolas J, Gatell JM, Miro JM, et al. Analysis of prognos-tic factors in 274 consecutive episodes of Pseudomonas aerug-inosa bacteremia. Antibiot Chemother 199144: 106-14.
   Google Scholar
• Mallolas J, Gatell JM, Miro JM, Marco F, Soriano E. Epi-demiologic characteristics and factors influencing the outcome of Pseudomonas aeruginosa bacteremia. Rev Infect Dis 1990; 12 (4): 718–9.
   PubMedGoogle Scholar
• Roche O, Beuhorry-Sassus F, Boillot A, et al. [Pseudomonas aeruginosa septicemia. Host-related risk factors in 82 episodes]. Presse Med 1995; 24 (25): 1164-6.
   Google Scholar
• Vidal F, Mensa J, Almela M, et al. Epidemiology and out-come of Pseudomonas aeruginosa bacteremia, with special em-phasis on the influence of antibiotic treatment. Analysis of 189 episodes. Arch Intern Med 1996; 156 (18): 2121-6.
   Google Scholar
• Siegman-Igra Y, Ravona R, Primerman H, Giladi M. Pseudomonas aeruginosa bacteremia: an analysis of 123 episodes, with particular emphasis on the effect of antibiotic ther-apy. Int J Infect Dis 1998; 2 (4): 211–5.
   PubMedGoogle Scholar
• Kuikka A, Valtonen VV. Factors associated with improved outcome of Pseudomonas aeruginosa bacteremia in a Finnish university hospital. Eur J Clin Microbiol Infect Dis 1998; 17 (10): 701–8.
   PubMed Web of Science ®Google Scholar
• Chatzinikolaou I, Abi-Said D, Bodey GP, Rolston KV, Tar-rand JJ, Samonis G. Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: Retrospective analysis of 245 episodes. Arch Intern Med 2000; 160 (4): 501–9.
   PubMedGoogle Scholar
• Pankhaniya RR, Tamura M, Allmond LR, et al. Pseudomonas aeruginosa causes acute lung injury via the cat-alytic activity of the patatin-like phospholipase domain of ExoU. Crit Care Med 2004; 32 (11): 2293–9.
   PubMed Web of Science ®Google Scholar
• Shaver CM, Hauser AR. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung. Infect Immun 2004; 72 (12): 6969–77.
   PubMed Web of Science ®Google Scholar
• Ma Q, Thai Y, Schneider JC, Ramseier TM, Saier MH, Jr. Protein secretion systems of Pseudomonas aeruginosa and P fluorescens. Biochim Biophys Acta 2003; 1611 (1-2): 223–33.
   PubMed Web of Science ®Google Scholar
• Nguyen L, Paulsen IT, Tchieu J, Hueck CJ, Saier MHJr. Phylogenetic analyses of the constituents of Type III protein se-cretion systems. J Mol Microbiol Biotechnol 2000; 2 (2): 125–44.
   PubMed Web of Science ®Google Scholar
• Hueck CJ. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev 1998; 62 (2): 379–433.
   PubMed Web of Science ®Google Scholar
• Yahr TL, Mende-Mueller LM, Friese MB, Frank DW. [den- tification of type III secreted products of the Pseudomonas aeruginosa exoenzyme S regulon. J Bacteriol 1997; 179 (22): 7165–8.
   PubMed Web of Science ®Google Scholar
• Yahr TL, Vallis AJ, Hancock MK, Barbieri JT, Frank DW. ExoY, an adenylate cyclase secreted by the Pseudomonas aerug-inosa type III system. Proc Natl Acad Sci U S A 1998; 95 (23): 13899–904.
   PubMed Web of Science ®Google Scholar
• Feltman H, Schulert G, Khan S, Jain M, Peterson L, Hauser AR. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Microbiol-ogy 2001; 147 (Pt 10): 2659–69.
   PubMed Web of Science ®Google Scholar
• Vance RE, Rietsch A, Mekalanos JJ. Role of the type III se-creted exoenzymes S, T, and Y in systemic spread of Pseudomonas aeruginosa PA01 in vivo. Infect Immun 2005; 73 (3): 1706–13.
   PubMed Web of Science ®Google Scholar
• Schulert GS, Feltman H, Rabin SD, et al. Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aerug-inosa isolates obtained from patients with hospital-acquired pneu-monia. J Infect Dis 2003; 188 (11): 1695–706.
   PubMed Web of Science ®Google Scholar
• Hauser AR, Cobb E, Bodi M, et al. Type III protein se-cretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aerug-inosa. Crit Care Med 2002; 30 (3): 521–8.
   PubMed Web of Science ®Google Scholar
• Roy-Burman A, Savel RH, Racine S, et al. Type III protein secretion is associated with death in lower respiratory and sys-temic Pseudomonas aeruginosa infections. J Infect Dis 2001; 183 (12): 1767–74.
   PubMed Web of Science ®Google Scholar
• Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of blood-stream infections on patient outcomes in the ICU setting. Chest 2000;118 (1): 146–55.
   PubMed Web of Science ®Google Scholar
• Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999; 115 (2): 462–74.
   PubMed Web of Science ®Google Scholar
• Harrington SM, Bishai WR. Chapter 8. Molecular epi-demiology and infectious diseases. In: Nelson KE, Williams CM, Graham CMH, eds. Infectious disease epidemiology Theory and Practice. 1st ed: Aspen Publishers, Gaithersburg, MD; 2001: 205-30.
   Google Scholar
• Tam VH, Chang KT, Larocco MT, et al. Prevalence, mechanisms, and risk factors of carbapenem resistance in blood-stream isolates of Pseudomonas aeruginosa. Diagn Microbiol Infect Dis 2007; 58 (3): 309–14.
   PubMed Web of Science ®Google Scholar
• Syrmis MW, O'Carroll MR, Sloots TP, et al. Rapid geno-typing of Pseudomonas aeruginosa isolates harboured by adult and paediatric patients with cystic fibrosis using repetitive-ele-ment-based PCR assays. J Med Microbiol 2004;53(Pt 11):1089–96.
   PubMed Web of Science ®Google Scholar
• Berthelot P, Attree I, Plesiat P, et al. Genotypic and phe-notypic analysis of type III secretion system in a cohort of Pseudomonas aeruginosa bacteremia isolates: evidence for a possible association between 0 serotypes and exo genes. J Infect Dis 2003; 188 (4): 512–8.
   PubMed Web of Science ®Google Scholar
• Ferrer M, Ioanas M, Arancibia F, Marco MA, de la Bella-casa JP, Torres A. Microbial airway colonization is associated with noninvasive ventilation failure in exacerbation of chronic ob-structive pulmonary disease. Crit Care Med 2005; 33 (9): 2003–9.
   PubMed Web of Science ®Google Scholar
• Thuong M, Arvaniti K, Ruimy R, et al. Epidemiology of Pseudomonas aeruginosa and risk factors for carriage acquisi-tion in an intensive care unit. J Hosp Infect 2003; 53 (4): 274–82.
   PubMed Web of Science ®Google Scholar
• Zhu H, Conibear TC, Bandara R, Aliwarga Y, Stapleton F, Willcox MD. Type III secretion system-associated toxins, pro-teases, serotypes, and antibiotic resistance of Pseudomonas aeruginosa isolates associated with keratitis. Curr Eye Res 2006; 31 (4): 297–306.
   PubMed Web of Science ®Google Scholar
• Holder IA, Neely AN, Frank DW. PcrV immunization en-hances survival of burned Pseudomonas aeruginosa-infected mice. Infect Immun 2001; 69 (9): 5908–10.
   PubMed Web of Science ®Google Scholar
• Sawa T, Yahr TL, Ohara M, et al. Active and passive im-munization with the Pseudomonas V antigen protects against type III intoxication and lung injury. Nat Med 1999; 5 (4): 392–8.
   PubMed Web of Science ®Google Scholar
• Joly B, Pierre M, Auvin S, et al. Relative expression of Pseudomonas aeruginosa virulence genes analyzed by a real time RT-PCR method during lung infection in rats. FEMS Mi-crobiol Lett 2005; 243 (1): 271–8.
   PubMed Web of Science ®Google Scholar